Filing Flows › Companies › Option Care Health › Timeline
Option Care Health stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+17.0% to $31.65
Option Care Health (OPCH) stock rose 17% over the last 252 sessions, to $31.65. On the way it reported 4 quarters, its insiders filed 6 open-market trades, and the company filed 3 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Nov 4, 2026 | Earnings | Earnings: beat the EPS estimate by 0.6% | −0.4% (−2.0% vs SPY) | — | — |
| Oct 6, 2026 | 8-K | Material definitive agreement | +28.2% (+27.7% vs SPY) | +28.6% (+28.1% vs SPY) | +30.7% (+33.4% vs SPY) |
| Jul 29, 2026 | Earnings | Earnings: beat the EPS estimate by 5.4% | +6.2% (+7.8% vs SPY) | +5.2% (+1.2% vs SPY) | +6.7% (+3.3% vs SPY) |
| May 7, 2026 | Insider buy | Sullivan Timothy P bought $500K | +1.5% (+1.8% vs SPY) | −3.3% (−4.5% vs SPY) | +0.3% (−0.2% vs SPY) |
| May 5, 2026 | 8-K | Directors and officers: departures, appointments, pay | −4.1% (−5.4% vs SPY) | −8.4% (−10.3% vs SPY) | −5.9% (−10.4% vs SPY) |
| May 4, 2026 | Insider buy | Sethna Meenal bought $327K | +5.4% (+5.8% vs SPY) | +2.4% (0.0% vs SPY) | +2.5% (−2.7% vs SPY) |
| May 4, 2026 | Insider buy | Rademacher John Charles bought $265K | +5.4% (+5.8% vs SPY) | +2.4% (0.0% vs SPY) | +2.5% (−2.7% vs SPY) |
| May 4, 2026 | Insider buy | Kraemer Harry M Jansen Jr. bought $784K | +5.4% (+5.8% vs SPY) | +2.4% (0.0% vs SPY) | +2.5% (−2.7% vs SPY) |
| Apr 30, 2026 | Earnings | Earnings: beat the EPS estimate by 8.1% | −27.9% (−28.9% vs SPY) | −27.3% (−30.4% vs SPY) | −25.3% (−31.4% vs SPY) |
| Apr 2, 2026 | 8-K | Material definitive agreement | +0.9% (+0.5% vs SPY) | +5.4% (+1.9% vs SPY) | −26.2% (−35.3% vs SPY) |
| Feb 27, 2026 | Insider sale | Pate R Carter sold $971K | +1.8% (+2.2% vs SPY) | −4.6% (−3.4% vs SPY) | −15.7% (−7.6% vs SPY) |
| Feb 27, 2026 | Insider sale | Bavaro Michael sold $198K | +1.8% (+2.2% vs SPY) | −4.6% (−3.4% vs SPY) | −15.7% (−7.6% vs SPY) |
| Feb 24, 2026 | Earnings | Earnings: missed the EPS estimate by -1.7% | −6.5% (−7.2% vs SPY) | −13.3% (−13.9% vs SPY) | −23.9% (−19.8% vs SPY) |
Insiders’ record here
In the year on the chart, Option Care Health's insiders reported 4 open-market buys ($1.9M) and 2 sales ($1.2M). Of the 6 old enough to score, 6 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was +4.6% and after a sale −46.0%.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
Report card: every quarter against the estimate → Option Care Health: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.